24/02/2018 - Sábado
08H00 Re-telling the thyroid cancer story: Rising incidence, mortality and an alternative explanation.
- Julie Ann Sosa
08H30 Active surveillance versus primary surgery for papillary microcarcinoma of the thyroid gland.
- Henning Dralle
09H00 Same thyroid cancer, different world practice guidelines, ethical and legal implications.
- Gláucia Mazeto
09H20 MicroRNAs in the thyroid. Use in the Differential Diagnosis of Thyroid Nodules.
- Nicole Massoll
09H50 Discussion
10H00 Break - Visit to exhibitors
10H20 Molecular-Directed Treatment of Differentiated Thyroid Cancer: Advances in Diagnosis and Treatment, patterns of use and cost.
- Hernán González
10H50 The evolving management of differentiated thyroid cancer: Is less more?
- Julie Ann Sosa
11H20 Presentation of Hypoparathyroidism: Etiologies, Clinical Features and treatment.
- Henning Dralle
11H50 Discussion
12H00 Break
  Moderator - Gustavo Caldas
13H30 Impact of pre operative ultrasonographic staging of the neck in papillary thyroid carcinoma.
- Hernán González
13H50 Postoperative non stimulated and stimulated thyroglobulin in the risk stratification and decision to perform 131I ablation.
- Pedro Weslley do Rosario
14H10 Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer.
- Rossella Elisei
14H30 Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. Relation with genomic alterations.
- Laura Ward
14H50 Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer. When and how to use T3.
- Danilo Villagelin
15H10 Discussion
15H20 Armadilhas no tratamento de CMT
- Dr. Cleber Camacho.
16H00 Break - Visit to exhibitors
  Moderator - Léa Maria Zanini Maciel
16H20 Utility of serum calcitonin for screening, risk stratification and treatment of medullary thyroid cancer.
- Henning Dralle
16H50 How does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
- Cléber Camacho
17H10 Medullary thyroid Cancer – Personal experience.
- Rossella Elisei
17H40 Discussion
25/02/2018 - Domingo
  Presenter - Bryan Mclver
08H00 Discuss Cases: Challenges in thyroid nodule workup from Imaging in Thyroid Cancer to Bethesda FNA Classification and Molecular Testing/Thyroid Cytopathology and treatment.
- Debaters: Eduardo Tomimori, Fabiano Callegari, Carolina Ferraz, Evandro Sobrosa e Frederico Maia
09H45 Break - Visit to exhibitors
  Presenter - Bryan Mclver
10H15 Discuss Thyroid Cancer Cases: Difficult management issues.
- Debaters: Luis Fernando Dias, Adriano Cury, Rosalia Padovani, Antonio Gonçalves e Venancio Alves
  Moderator - Gustavo Caldas
14H00 Controversies around metastatic lymph nodes: What do they mean in young patients, and how many do you need to remove?
- Julie Ann Sosa
14H30 Serum positive thyroglobulin antibodies: Implications and strategies.
- Fernanda Vaisman
14H50 Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
- Denise Momesso
15H10 Postoperative surveillance of thyroid carcinoma
- Bryan Mclver
15H30 Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
- Erivelto Volpi
15H50 Discussion
16H00 Break - Visit to exhibitors
  Presenter - Rossella Elisei
16H30 Discuss Thyroid Cancer Cases: Strategies for Detection of Recurrent Disease and treatment in Long–Term Follow–up.
- Debaters: Debora Danilovic, George Coura Filho, Ana Hoff e Rosalinda Camargo